Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 39Gynecologic 12CNS 5Breast 4Other neoplasm 3Lymphoid 3Gastrointestinal 3Other hematologic neoplasm 2Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1

Conditions

Breast Neoplasms 4Stomach Neoplasms 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 183Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 93Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Imiquimod × Breast × Clear all
NCT01421017 2021-11-18

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

NYU Langone Health

Phase 1/2 Completed
31 enrolled 11 charts
Breast

Breast Neoplasms

NCT02276300 2019-11-20

HER2

Technical University of Munich

Phase 1 Completed
2 enrolled
BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT00821964 2018-01-02

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

University of Washington

Phase 2 Completed
15 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00899574 2015-12-07

Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases

NYU Langone Health

Phase 2 Completed
10 enrolled 5 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡